PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16433037-3	2006	Seven benzo[a]phenoxazines were observed to increase the amount of rhodamine 123 accumulated by resistant cells, i.e. to be new effective MDR modulators.	Rhodamines	67-76	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	138-141	
17635801-2	2007	In this study, the activities of two members of the superfamily of ATP-binding cassette (ABC) transport proteins, ABCB1 and ABCC (measured by rhodamine 123 efflux and Fluo-3 efflux respectively), were compared in murine bone marrow cells and thymocytes of young (3-4 weeks old), adult (2-3 months old) and old (18 months old) mice.	Rhodamines	142-151	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	114-119	
22451472-3	2012	Multidrug resistance protein 1 blockade by the specific inhibitor reduced the percentage of rhodamine 123(low) cells in LDCs from aged mice (54.8% +- 2.6% to 13.2% +- 2.5%, p < .01).	Rhodamines	92-101	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	0-30	
21711510-10	2011	Moreover, the markedly increased Abcb1a/Abcb1b expression was correlated to an efficient Rhodamine 123 efflux, which was completely inhibited by verapamil, a well-known Abcb1a/Abcb1b inhibitor.	Rhodamines	89-98	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	40-46	
21711510-10	2011	Moreover, the markedly increased Abcb1a/Abcb1b expression was correlated to an efficient Rhodamine 123 efflux, which was completely inhibited by verapamil, a well-known Abcb1a/Abcb1b inhibitor.	Rhodamines	89-98	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	176-182	
14502537-7	2003	Rhodamine 123 efflux was reduced by dexloxiglumide from 4.06 (+/-0.34) to 2.84 (+/-0.15) across Caco-2 monolayers, and from 17.3 (+/-0.9) to 8.26 (+/-1.38) across MDR1-MDCK monolayers, further indicating dexloxiglumide interaction with P-gp.	Rhodamines	0-9	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	163-167	
12589934-7	2002	Functional Abcb1a/Abcb1b was detected by inhibition of rhodamine efflux by these drugs and mRNA for Abcb1a and Abcb1b were detected in these cells.	Rhodamines	55-64	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	18-24	
11235562-4	2000	The functional activity of mdr1 in transfected cells was examined by rhodamine retention assay.	Rhodamines	69-78	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	27-31	
11776553-3	1999	Pgp, a product of mdr1 gene expression, and its function were detected by flow cytometry, immunohistochemistry, and rhodamine test respectively.	Rhodamines	116-125	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	18-22	
9108099-7	1997	However, both mdr1a and mdr1b P-gps contributed to the extrusion of rhodamine from hematopoietic progenitor cells, suggesting a potential role for the endogenous mdr1-type P-gps in protection of bone marrow against cytotoxic anticancer drugs.	Rhodamines	68-77	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	24-29	
9108099-7	1997	However, both mdr1a and mdr1b P-gps contributed to the extrusion of rhodamine from hematopoietic progenitor cells, suggesting a potential role for the endogenous mdr1-type P-gps in protection of bone marrow against cytotoxic anticancer drugs.	Rhodamines	68-77	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	14-18	
7847840-5	1994	This indicates that the rhodamine efflux is a more function-related marker for MDR than the mdr1 gene and the pgp.	Rhodamines	24-33	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	92-96	
8650203-5	1996	Most importantly, reserpine and doxorubicin completely abolish Mdr1-mediated rhodamine resistance.	Rhodamines	77-86	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	63-67